Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105559

The Anticoagulant Activity of Lysosomal Cationic Proteins from Polymorphonuclear Leukocytes

Hussain I. Saba, Harold R. Roberts, and John C. Herion

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C.

Department of Pathology, University of North Carolina School of Medicine, Chapel Hill, N. C.

†

U. S. Public Health Service fellow in hematology.

‡

Address requests for reprints to Dr. John C. Herion, Dept. of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C. 27514.

*

Submitted for publication July 7, 1966; accepted December 22, 1966.

Supported in part by U. S. Public Health Service grants AI 04925, HE 06350, and TI AM 5345.

Find articles by Saba, H. in: JCI | PubMed | Google Scholar

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C.

Department of Pathology, University of North Carolina School of Medicine, Chapel Hill, N. C.

†

U. S. Public Health Service fellow in hematology.

‡

Address requests for reprints to Dr. John C. Herion, Dept. of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C. 27514.

*

Submitted for publication July 7, 1966; accepted December 22, 1966.

Supported in part by U. S. Public Health Service grants AI 04925, HE 06350, and TI AM 5345.

Find articles by Roberts, H. in: JCI | PubMed | Google Scholar

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C.

Department of Pathology, University of North Carolina School of Medicine, Chapel Hill, N. C.

†

U. S. Public Health Service fellow in hematology.

‡

Address requests for reprints to Dr. John C. Herion, Dept. of Medicine, University of North Carolina School of Medicine, Chapel Hill, N. C. 27514.

*

Submitted for publication July 7, 1966; accepted December 22, 1966.

Supported in part by U. S. Public Health Service grants AI 04925, HE 06350, and TI AM 5345.

Find articles by Herion, J. in: JCI | PubMed | Google Scholar

Published April 1, 1967 - More info

Published in Volume 46, Issue 4 on April 1, 1967
J Clin Invest. 1967;46(4):580–589. https://doi.org/10.1172/JCI105559.
© 1967 The American Society for Clinical Investigation
Published April 1, 1967 - Version history
View PDF
Abstract

A cationic protein fraction from rabbit polymorphonuclear leukocyte lysosomes has been shown to exert a potent anticoagulant effect on human blood in vitro. The anticoagulant activity is detectable in the whole blood clotting time, the recalcification time of platelet-rich plasma, the prothrombin time, the partial thromboplastin time, and the thromboplastin generation test. The lysosomal cationic proteins do not inhibit any of the known specific procoagulants. They appear to inhibit clotting by blocking the formation of intrinsic thromboplastin possibly by interfering with the role of phospholipids in the reaction involving Factors V and X and calcium.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 580
page 580
icon of scanned page 581
page 581
icon of scanned page 582
page 582
icon of scanned page 583
page 583
icon of scanned page 584
page 584
icon of scanned page 585
page 585
icon of scanned page 586
page 586
icon of scanned page 587
page 587
icon of scanned page 588
page 588
icon of scanned page 589
page 589
Version history
  • Version 1 (April 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts